Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Healthtrust
Johnson and Johnson
Citi
Julphar
Fish and Richardson
Argus Health
AstraZeneca
Merck
Fuji

Generated: October 23, 2017

DrugPatentWatch Database Preview

Details for Patent: 6,361,758

« Back to Dashboard

Which drugs does patent 6,361,758 protect, and when does it expire?


Patent 6,361,758 protects ZEMPLAR and is included in one NDA. There have been three Paragraph IV challenges on Zemplar.

Protection for ZEMPLAR has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

Summary for Patent: 6,361,758

Title: Cosolvent formulations
Abstract:Stable pharmaceutical formulations of a therapeutic agent, a low molecular weight alcohol and a glycol derivative are disclosed. Preferred formulations include 19-nor-1.alpha.,3.beta.,25-trihydroxy-9,10-secoergosta-5,7(E),22(E)-triene .
Inventor(s): Li; Lukchiu (Vernon Hills, IL), Pec; Edward Anthony (Gurnee, IL), Robinson; Daniel H. (Lake Bluff, IL), Stephens; Dennis A. (Mt. Prospect, IL), Jantzi; Kathee (Madison, WI), May; Thomas Barton (Grayslake, IL), Oberdier; John Paul (Gurnee, IL)
Assignee: Abbott Laboratories (Abbott Park, IL)
Application Number:09/689,507
Patent Claim Types:
see list of patent claims
Composition; Formulation;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Abbvie
ZEMPLAR
paricalcitol
SOLUTION;INTRAVENOUS020819-002Feb 1, 2000APRXYesYes► Subscribe► SubscribeY
Abbvie
ZEMPLAR
paricalcitol
SOLUTION;INTRAVENOUS020819-001Apr 17, 1998APRXYesYes► Subscribe► SubscribeY
Abbvie
ZEMPLAR
paricalcitol
SOLUTION;INTRAVENOUS020819-003Feb 1, 2000APRXYesYes► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
QuintilesIMS
Citi
Fuji
Accenture
Boehringer Ingelheim
Cerilliant
US Department of Justice
Colorcon
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot